United States Renal Data System: Annual data report. 2018. Available at: https://www.usrds.org/media/1736/v2_c01_incprev_18_usrds.pdf. Accessed October 18, 2020)| false
National Kidney Foundation: A clinical update on dialyzer membranes. Available at: https://www.kidney.org/sites/default/files/02-10-6050_FBD_Clinical_bulletin.pdf. Accessed October 22, 2020)| false
GuraV, DavenportA, BeizaiM, EzonC, RoncoC: Beta2-microglobulin and phosphate clearances using a wearable artificial kidney: a pilot study. Am J Kidney Dis54: 104–111, 2009PubMed
GuraV, DavenportA, BeizaiM, EzonC, RoncoC: Beta2-microglobulin and phosphate clearances using a wearable artificial kidney: a pilot study. Am J Kidney Dis 54: 104–111, 2009PubMed)| false
SandemanSR, HowellCA, PhillipsGJ, ZhengY, StandenG, PletzenauerR, et al.: An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med25: 1589–1597, 2014PubMed
SandemanSR, HowellCA, PhillipsGJ, ZhengY, StandenG, PletzenauerR, : An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med 25: 1589–1597, 2014PubMed)| false
KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis48: S1–S322, 2006PubMed
KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 48: S1–S322, 2006PubMed)| false
MoistLM, HemmelgarnBR, LokCE: Relationship between blood flow in central venous catheters and hemodialysis adequacy. Clin J Am Soc Nephrol1: 965–971, 2006PubMed
MoistLM, HemmelgarnBR, LokCE: Relationship between blood flow in central venous catheters and hemodialysis adequacy. Clin J Am Soc Nephrol 1: 965–971, 2006PubMed)| false
ChangKY, KimSH, KimYO, JinDC, SongHC, ChoiEJ, et al.: The impact of blood flow rate during hemodialysis on all-cause mortality. Korean J Intern Med (Korean Assoc Intern Med)31: 1131–1139, 2016PubMed
ChangKY, KimSH, KimYO, JinDC, SongHC, ChoiEJ, : The impact of blood flow rate during hemodialysis on all-cause mortality. Korean J Intern Med (Korean Assoc Intern Med) 31: 1131–1139, 2016PubMed)| false
LeypoldtJK, CheungAK, AgodoaLY, DaugirdasJT, GreeneT, KeshaviahPR: Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int51: 2013–2017, 1997PubMed
LeypoldtJK, CheungAK, AgodoaLY, DaugirdasJT, GreeneT, KeshaviahPR: Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int 51: 2013–2017, 1997PubMed)| false
GaulyA, ParisottoMT, SkinderA, SchoderV, FurlanA, SchuhE, et al.: Vascular access cannulation in hemodialysis patients: A survey of current practice and its relation to dialysis dose. J Vasc Access12: 358–364, 2011PubMed
GaulyA, ParisottoMT, SkinderA, SchoderV, FurlanA, SchuhE, : Vascular access cannulation in hemodialysis patients: A survey of current practice and its relation to dialysis dose. J Vasc Access 12: 358–364, 2011PubMed)| false
SchmidliJ, WidmerMK, BasileC, de DonatoG, GallieniM, GibbonsCP, et al.; ESVS Guidelines Committee: Editor’s choice - vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg55: 757–818, 2018PubMed
SchmidliJ, WidmerMK, BasileC, de DonatoG, GallieniM, GibbonsCP, ; ESVS Guidelines Committee: Editor’s choice - vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 55: 757–818, 2018PubMed)| false
National Kidney Foundation. Clinical Update. Needles and cannulas for arteriovenous fistula access: more options promote better outcomes. 2016. Available at: https://www.kidney.org/sites/default/files/Fistula%20Bulletin_0.pdf Accessed October 22, 2020)| false
ParisottoMT, PellicciaF, GrassmannA, MarcelliD: Elements of dialysis nursing practice associated with successful cannulation: Result of an international survey. J Vasc Access18: 114–119, 2017PubMed
ParisottoMT, PellicciaF, GrassmannA, MarcelliD: Elements of dialysis nursing practice associated with successful cannulation: Result of an international survey. J Vasc Access 18: 114–119, 2017PubMed)| false
FerreyA, YouAS, KovesdyCP, NakataT, VelizM, NguyenDV, et al.: Dialysate potassium and mortality in a prospective hemodialysis cohort. Am J Nephrol47: 415–423, 2018PubMed
FerreyA, YouAS, KovesdyCP, NakataT, VelizM, NguyenDV, : Dialysate potassium and mortality in a prospective hemodialysis cohort. Am J Nephrol 47: 415–423, 2018PubMed)| false
BrunelliSM, SpiegelDM, Du MondC, OestreicherN, WinkelmayerWC, KovesdyCP: Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant33: 1207–1214, 2018PubMed
BrunelliSM, SpiegelDM, Du MondC, OestreicherN, WinkelmayerWC, KovesdyCP: Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant 33: 1207–1214, 2018PubMed)| false
KovesdyCP, RegidorDL, MehrotraR, JingJ, McAllisterCJ, GreenlandS, et al.: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol2: 999–1007, 2007PubMed
KovesdyCP, RegidorDL, MehrotraR, JingJ, McAllisterCJ, GreenlandS, : Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999–1007, 2007PubMed)| false
KaraboyasA, ZeeJ, BrunelliSM, UsvyatLA, WeinerDE, MadduxFW, et al.: Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: Results from the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis69: 266–277, 2017PubMed
KaraboyasA, ZeeJ, BrunelliSM, UsvyatLA, WeinerDE, MadduxFW, : Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: Results from the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 69: 266–277, 2017PubMed)| false
HeckingM, KaraboyasA, SaranR, SenA, HörlWH, PisoniRL, et al.: Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis59: 238–248, 2012PubMed
HeckingM, KaraboyasA, SaranR, SenA, HörlWH, PisoniRL, : Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 59: 238–248, 2012PubMed)| false
ChauhanK, PattharanitimaP, PatelN, DuffyA, SahaA, ChaudharyK, et al.: Rate of correction of hypernatremia and health outcomes in critically ill patients. Clin J Am Soc Nephrol14: 656–663, 2019PubMed
ChauhanK, PattharanitimaP, PatelN, DuffyA, SahaA, ChaudharyK, : Rate of correction of hypernatremia and health outcomes in critically ill patients. Clin J Am Soc Nephrol 14: 656–663, 2019PubMed)| false
National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis42[Suppl 3]: S1–S201, 2003PubMed
National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1–S201, 2003PubMed)| false
Kidney Disease: Improving Global Outcomes CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl76[suppl 113]: S1–S130, 2009
Kidney Disease: Improving Global Outcomes CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 76[suppl 113]: S1–S130, 2009)| false
WangZ, JiangA, WeiF, ChenH: Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: A meta-analysis. BMC Cardiovasc Disord18: 12, 2018PubMed
WangZ, JiangA, WeiF, ChenH: Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: A meta-analysis. BMC Cardiovasc Disord 18: 12, 2018PubMed)| false
ShermanRA, BialyGB, GazinskiB, BernholcAS, EisingerRP: The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis8: 244–247, 1986PubMed
ShermanRA, BialyGB, GazinskiB, BernholcAS, EisingerRP: The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis 8: 244–247, 1986PubMed)| false
PunPH, HortonJR, MiddletonJP: Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol8: 797–803, 2013PubMed
PunPH, HortonJR, MiddletonJP: Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol 8: 797–803, 2013PubMed)| false
SakohT, TaniguchiM, YamadaS, OhnakaS, AraseH, TokumotoM, et al.: Short- and long-term effects of dialysate calcium concentrations on mineral and bone metabolism in hemodialysis patients: The K4 study. Kidney Med1: 296–306, 2019PubMed
SakohT, TaniguchiM, YamadaS, OhnakaS, AraseH, TokumotoM, : Short- and long-term effects of dialysate calcium concentrations on mineral and bone metabolism in hemodialysis patients: The K4 study. Kidney Med 1: 296–306, 2019PubMed)| false
SheridanK, LogomarsinoJV: Effects of serum phosphorus on vascular calcification in a healthy, adult population: A systematic review. J Vasc Nurs35: 157–169, 2017PubMed
SheridanK, LogomarsinoJV: Effects of serum phosphorus on vascular calcification in a healthy, adult population: A systematic review. J Vasc Nurs 35: 157–169, 2017PubMed)| false
CozzolinoM, CiceriP, GalassiA, ManganoM, CarugoS, CapelliI, et al.: The key role of phosphate on vascular calcification. Toxins (Basel)11: 213, 2019PubMed
CozzolinoM, CiceriP, GalassiA, ManganoM, CarugoS, CapelliI, : The key role of phosphate on vascular calcification. Toxins (Basel) 11: 213, 2019PubMed)| false
BergmarkBA, UdellJA, MorrowDA, CannonCP, SteenDL, JarolimP, et al.: Association of fibroblast growth factor 23 with recurrent cardiovascular events in patients after an acute coronary syndrome: A secondary analysis of a randomized clinical trial. JAMA Cardiol3: 473–480, 2018PubMed
BergmarkBA, UdellJA, MorrowDA, CannonCP, SteenDL, JarolimP, : Association of fibroblast growth factor 23 with recurrent cardiovascular events in patients after an acute coronary syndrome: A secondary analysis of a randomized clinical trial. JAMA Cardiol 3: 473–480, 2018PubMed)| false
DaugirdasJT, ChertowGM, LariveB, PierratosA, GreeneT, AyusJC, et al.; Frequent Hemodialysis Network (FHN) Trial Group: Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol23: 727–738, 2012PubMed
DaugirdasJT, ChertowGM, LariveB, PierratosA, GreeneT, AyusJC, ; Frequent Hemodialysis Network (FHN) Trial Group: Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol 23: 727–738, 2012PubMed)| false
FangYW, LeuJG, TsaiMH, LiouHH: Higher intra-dialysis serum phosphorus reduction ratio as a predictor of mortality in patients on long-term hemodialysis. Med Sci Monit25: 691–699, 2019\PubMed
FangYW, LeuJG, TsaiMH, LiouHH: Higher intra-dialysis serum phosphorus reduction ratio as a predictor of mortality in patients on long-term hemodialysis. Med Sci Monit 25: 691–699, 2019\PubMed)| false
OchiA, IshimuraE, TsujimotoY, KakiyaR, TabataT, MoriK, et al.: Hair magnesium, but not serum magnesium, is associated with left ventricular wall thickness in hemodialysis patients. Circ J77: 3029–3036, 2013PubMed
OchiA, IshimuraE, TsujimotoY, KakiyaR, TabataT, MoriK, : Hair magnesium, but not serum magnesium, is associated with left ventricular wall thickness in hemodialysis patients. Circ J 77: 3029–3036, 2013PubMed)| false
SakaguchiY, FujiiN, ShojiT, HayashiT, RakugiH, IsakaY: Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int85: 174–181, 2014PubMed
SakaguchiY, FujiiN, ShojiT, HayashiT, RakugiH, IsakaY: Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 85: 174–181, 2014PubMed)| false
Ter BraakeAD, ShanahanCM, de BaaijJHF: Magnesium counteracts vascular calcification: Passive interference or active modulation?Arterioscler Thromb Vasc Biol37: 1431–1445, 2017PubMed
Ter BraakeAD, ShanahanCM, de BaaijJHF: Magnesium counteracts vascular calcification: Passive interference or active modulation?Arterioscler Thromb Vasc Biol 37: 1431–1445, 2017PubMed)| false
FeinP, SudaV, BorawskyC, KapuparaH, ButikisA, MatzaB, et al.: Relationship of serum magnesium to body composition and inflammation in peritoneal dialysis patients. Adv Perit Dial26: 112–115, 2010PubMed
FeinP, SudaV, BorawskyC, KapuparaH, ButikisA, MatzaB, : Relationship of serum magnesium to body composition and inflammation in peritoneal dialysis patients. Adv Perit Dial 26: 112–115, 2010PubMed)| false
MizuiriS, NishizawaY, YamashitaK, OnoK, UsuiK, AritaM, et al.: Relationship of serum magnesium level with body composition and survival in hemodialysis patients. Hemodial Int24: 99–107, 2020PubMed
MizuiriS, NishizawaY, YamashitaK, OnoK, UsuiK, AritaM, : Relationship of serum magnesium level with body composition and survival in hemodialysis patients. Hemodial Int 24: 99–107, 2020PubMed)| false
DekkerMJE, KoningsC, CanaudB, van der SandeFM, StuardS, RaimannJG, et al.: Interactions between malnutrition, inflammation, and fluid overload and their associations with survival in prevalent hemodialysis patients. J Ren Nutr28: 435–444, 2018PubMed
DekkerMJE, KoningsC, CanaudB, van der SandeFM, StuardS, RaimannJG, : Interactions between malnutrition, inflammation, and fluid overload and their associations with survival in prevalent hemodialysis patients. J Ren Nutr 28: 435–444, 2018PubMed)| false
BressendorffI, HansenD, SchouM, PaschA, BrandiL: The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: A randomized, controlled clinical trial. Clin J Am Soc Nephrol13: 1373–1380, 2018PubMed
BressendorffI, HansenD, SchouM, PaschA, BrandiL: The effect of increasing dialysate magnesium on serum calcification propensity in subjects with end stage kidney disease: A randomized, controlled clinical trial. Clin J Am Soc Nephrol 13: 1373–1380, 2018PubMed)| false
SakaguchiY, HamanoT, IsakaY: Magnesium in hemodialysis patients: A new understanding of the old problem. Contrib Nephrol196: 58–63, 2018PubMed
SakaguchiY, HamanoT, IsakaY: Magnesium in hemodialysis patients: A new understanding of the old problem. Contrib Nephrol 196: 58–63, 2018PubMed)| false
YuL, SongJ, LuX, ZuY, LiH, WangS: Association between serum magnesium and erythropoietin responsiveness in hemodialysis patients: A cross-sectional study. Kidney Blood Press Res44: 354–361, 2019PubMed
YuL, SongJ, LuX, ZuY, LiH, WangS: Association between serum magnesium and erythropoietin responsiveness in hemodialysis patients: A cross-sectional study. Kidney Blood Press Res 44: 354–361, 2019PubMed)| false
ParsonsFM, StewartWK: The composition of dialysis fluid. In: Replacement of Renal Function by Dialysis, 2nd Ed., edited by DrukkerW, ParsonsFM, MaherJF, Boston, Maritnus, Nijhoff, 1983, pp 148–170
ParsonsFM, StewartWK: The composition of dialysis fluid. In: Replacement of Renal Function by Dialysis, 2nd Ed., edited by DrukkerW, ParsonsFM, MaherJF, Boston, Maritnus, Nijhoff, 1983, pp 148–170)| false
WathenRL, KeshaviahP, HommeyerP, CadwellK, ComtyCM: The metabolic effects of hemodialysis with and without glucose in the dialysate. Am J Clin Nutr31: 1870–1875, 1978PubMed
WathenRL, KeshaviahP, HommeyerP, CadwellK, ComtyCM: The metabolic effects of hemodialysis with and without glucose in the dialysate. Am J Clin Nutr 31: 1870–1875, 1978PubMed)| false
SaranR, Bragg-GreshamJL, LevinNW, TwardowskiZJ, WizemannV, SaitoA, et al.: Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int69: 1222–1228, 2006PubMed
SaranR, Bragg-GreshamJL, LevinNW, TwardowskiZJ, WizemannV, SaitoA, : Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int 69: 1222–1228, 2006PubMed)| false
KimTW, ChangTI, KimTH, ChouJA, SoohooM, RavelVA, et al.: Association of ultrafiltration rate with mortality in incident hemodialysis patients. Nephron139: 13–22, 2018PubMed
KimTW, ChangTI, KimTH, ChouJA, SoohooM, RavelVA, : Association of ultrafiltration rate with mortality in incident hemodialysis patients. Nephron 139: 13–22, 2018PubMed)| false
FlytheJE, KimmelSE, BrunelliSM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int79: 250–257, 2011PubMed
FlytheJE, KimmelSE, BrunelliSM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79: 250–257, 2011PubMed)| false
BreidthardtT, BurtonJO, OduduA, EldehniMT, JefferiesHJ, McIntyreCW: Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol7: 1285–1292, 2012PubMed
BreidthardtT, BurtonJO, OduduA, EldehniMT, JefferiesHJ, McIntyreCW: Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol 7: 1285–1292, 2012PubMed)| false
DaugirdasJT, SchneditzD: Hemodialysis ultrafiltration rate targets should be scaled to body surface area rather than to body weight. Semin Dial30: 15–19, 2017PubMed
DaugirdasJT, SchneditzD: Hemodialysis ultrafiltration rate targets should be scaled to body surface area rather than to body weight. Semin Dial 30: 15–19, 2017PubMed)| false
LiangXK, LiLJ, WangXH, WangXX, WangYD, XuZF: Role of lung ultrasound in adjusting ultrafiltration volume in hemodialysis patients. Ultrasound Med Biol45: 732–740, 2019PubMed
LiangXK, LiLJ, WangXH, WangXX, WangYD, XuZF: Role of lung ultrasound in adjusting ultrafiltration volume in hemodialysis patients. Ultrasound Med Biol 45: 732–740, 2019PubMed)| false
DaugirdasJT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol4: 1205–1213, 1993PubMed
DaugirdasJT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4: 1205–1213, 1993PubMed)| false
SpaldingEM, ChandnaSM, DavenportA, FarringtonK: Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int74: 348–355, 2008PubMed
SpaldingEM, ChandnaSM, DavenportA, FarringtonK: Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int 74: 348–355, 2008PubMed)| false
PerlJ, DemberLM, BargmanJM, BrowneT, CharytanDM, FlytheJE, et al.; American Society of Nephrology Dialysis Advisory Group: The use of a multidimensional measure of dialysis adequacy: Moving beyond small solute kinetics. Clin J Am Soc Nephrol12: 839–847, 2017PubMed
PerlJ, DemberLM, BargmanJM, BrowneT, CharytanDM, FlytheJE, ; American Society of Nephrology Dialysis Advisory Group: The use of a multidimensional measure of dialysis adequacy: Moving beyond small solute kinetics. Clin J Am Soc Nephrol 12: 839–847, 2017PubMed)| false
WooK, LokCE: New insights into dialysis vascular access: What is the optimal vascular access type and timing of access creation in CKD and dialysis patients?Clin J Am Soc Nephrol11: 1487–1494, 2016PubMed
WooK, LokCE: New insights into dialysis vascular access: What is the optimal vascular access type and timing of access creation in CKD and dialysis patients?Clin J Am Soc Nephrol 11: 1487–1494, 2016PubMed)| false
PilladoE, BehdadM, WilliamsR, WilsonSE: Flow rates at thirty days after construction of radiocephalic arteriovenous fistula predict hemodialysis function. Ann Vasc Surg49: 268–272, 2018PubMed
PilladoE, BehdadM, WilliamsR, WilsonSE: Flow rates at thirty days after construction of radiocephalic arteriovenous fistula predict hemodialysis function. Ann Vasc Surg 49: 268–272, 2018PubMed)| false
QuinnRR, OliverMJ, DevoeD, PoinenK, KabaniR, KamarF, et al.: The effect of predialysis fistula attempt on risk of all-cause and access-related death. J Am Soc Nephrol28: 613–620, 2017PubMed
QuinnRR, OliverMJ, DevoeD, PoinenK, KabaniR, KamarF, : The effect of predialysis fistula attempt on risk of all-cause and access-related death. J Am Soc Nephrol 28: 613–620, 2017PubMed)| false
HuangSS, MacRaeJ, RossD, ImtiazR, HollingsworthB, NesrallahGE, et al.: Buttonhole versus stepladder cannulation for home hemodialysis: A multicenter, randomized, pilot trial. Clin J Am Soc Nephrol14: 403–410, 2019PubMed
HuangSS, MacRaeJ, RossD, ImtiazR, HollingsworthB, NesrallahGE, : Buttonhole versus stepladder cannulation for home hemodialysis: A multicenter, randomized, pilot trial. Clin J Am Soc Nephrol 14: 403–410, 2019PubMed)| false
ViecelliAK, TongA, O’LoneE, JuA, HansonCS, SautenetB, et al.; SONG-HD Vascular Access Workshop Investigators: Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop on establishing a core outcome measure for hemodialysis vascular access. Am J Kidney Dis71: 690–700, 2018PubMed
ViecelliAK, TongA, O’LoneE, JuA, HansonCS, SautenetB, ; SONG-HD Vascular Access Workshop Investigators: Report of the standardized outcomes in nephrology-hemodialysis (SONG-HD) consensus workshop on establishing a core outcome measure for hemodialysis vascular access. Am J Kidney Dis 71: 690–700, 2018PubMed)| false
LinYF, HuangJW, WuMS, ChuTS, LinSL, ChenYM, et al.: Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton)14: 59–64, 2009PubMed
LinYF, HuangJW, WuMS, ChuTS, LinSL, ChenYM, : Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton) 14: 59–64, 2009PubMed)| false
MathewAT, FishbaneS, ObiY, Kalantar-ZadehK: Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int90: 262–271, 2016PubMed
MathewAT, FishbaneS, ObiY, Kalantar-ZadehK: Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 90: 262–271, 2016PubMed)| false
GolperTA, MehrotraR: The intact nephron hypothesis in reverse: An argument to support incremental dialysis. Nephrol Dial Transplant30: 1602–1604, 2015PubMed
GolperTA, MehrotraR: The intact nephron hypothesis in reverse: An argument to support incremental dialysis. Nephrol Dial Transplant 30: 1602–1604, 2015PubMed)| false
GrubbsV, MossAH, CohenLM, FischerMJ, GermainMJ, JassalSV, et al.; Dialysis Advisory Group of the American Society of Nephrology: A palliative approach to dialysis care: A patient-centered transition to the end of life. Clin J Am Soc Nephrol9: 2203–2209, 2014PubMed
GrubbsV, MossAH, CohenLM, FischerMJ, GermainMJ, JassalSV, ; Dialysis Advisory Group of the American Society of Nephrology: A palliative approach to dialysis care: A patient-centered transition to the end of life. Clin J Am Soc Nephrol 9: 2203–2209, 2014PubMed)| false
EknoyanJ, BeckGJ, CheungAK, DaugirdasJT, GreeneT, KusekJW, et al.; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med347: 2010–2019, 2002
EknoyanJ, BeckGJ, CheungAK, DaugirdasJT, GreeneT, KusekJW, ; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010–2019, 2002)| false
ChertowGM, LevinNW, BeckGJ, DepnerTA, EggersPW, GassmanJJ, et al.; FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med363: 2287–2300, 2010PubMed
ChertowGM, LevinNW, BeckGJ, DepnerTA, EggersPW, GassmanJJ, ; FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287–2300, 2010PubMed)| false
FliserD, SchröterM, NeubeckM, RitzE: Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int46: 482–488, 1994PubMed
FliserD, SchröterM, NeubeckM, RitzE: Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 46: 482–488, 1994PubMed)| false
YanY, WangM, ZeeJ, SchauberD, TuC, QianJ, et al.: Twice-weekly hemodialysis and clinical outcomes in the China dialysis outcomes and practice pattern study. Kidney Int Rep3: 889–896, 2018PubMed
YanY, WangM, ZeeJ, SchauberD, TuC, QianJ, : Twice-weekly hemodialysis and clinical outcomes in the China dialysis outcomes and practice pattern study. Kidney Int Rep 3: 889–896, 2018PubMed)| false
WolleyM, JardineM, HutchisonCA: Exploring the clinical relevance of providing increased removal of large middle molecules. Clin J Am Soc Nephrol13: 805–814, 2018PubMed
WolleyM, JardineM, HutchisonCA: Exploring the clinical relevance of providing increased removal of large middle molecules. Clin J Am Soc Nephrol 13: 805–814, 2018PubMed)| false
WeinerDE, FalzonL, SkoufosL, BernardoA, BeckW, XiaoM, et al.: Efficacy and safety of expanded hemodialysis with the Theranova 400 dialyzer: A randomized controlled trial. Clin J Am Soc Nephrol15: 1310–1319, 2020PubMed
WeinerDE, FalzonL, SkoufosL, BernardoA, BeckW, XiaoM, : Efficacy and safety of expanded hemodialysis with the Theranova 400 dialyzer: A randomized controlled trial. Clin J Am Soc Nephrol 15: 1310–1319, 2020PubMed)| false
García-PrietoA, VegaA, LinaresT, AbadS, MacíasN, AragoncilloI, et al.: Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration. Clin Kidney J11: 742–746, 2018PubMed
García-PrietoA, VegaA, LinaresT, AbadS, MacíasN, AragoncilloI, : Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration. Clin Kidney J 11: 742–746, 2018PubMed)| false
LiZ, LacsonEJr, LowrieEG, OfsthunNJ, KuhlmannMK, LazarusJM, et al.: The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis48: 606–615, 2006PubMed
LiZ, LacsonEJr, LowrieEG, OfsthunNJ, KuhlmannMK, LazarusJM, : The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 48: 606–615, 2006PubMed)| false
AgarwalR, AndersenMJ, LightRP: Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol28: 210–217, 2008PubMed
AgarwalR, AndersenMJ, LightRP: Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Am J Nephrol 28: 210–217, 2008PubMed)| false
BansalN, McCullochCE, RahmanM, KusekJW, AndersonAH, XieD, et al.; CRIC Study Investigators: Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: The chronic renal insufficiency cohort study. Hypertension65: 93–100, 2015PubMed
BansalN, McCullochCE, RahmanM, KusekJW, AndersonAH, XieD, ; CRIC Study Investigators: Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: The chronic renal insufficiency cohort study. Hypertension 65: 93–100, 2015PubMed)| false
AlborziP, PatelN, AgarwalR: Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol2: 1228–1234, 2007PubMed
AlborziP, PatelN, AgarwalR: Home blood pressures are of greater prognostic value than hemodialysis unit recordings. Clin J Am Soc Nephrol 2: 1228–1234, 2007PubMed)| false
ShafiT, SozioSM, Bandeen-RocheKJ, EphraimPL, LulyJR, St PeterWL, et al.; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators: Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol25: 799–809, 2014PubMed
ShafiT, SozioSM, Bandeen-RocheKJ, EphraimPL, LulyJR, St PeterWL, ; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators: Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol 25: 799–809, 2014PubMed)| false
KlassenPS, LowrieEG, ReddanDN, DeLongER, ColadonatoJA, SzczechLA, et al.: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA287: 1548–1555, 2002PubMed
KlassenPS, LowrieEG, ReddanDN, DeLongER, ColadonatoJA, SzczechLA, : Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287: 1548–1555, 2002PubMed)| false
ChangTI: Timing of antihypertensive medications on key outcomes in hemodialysis (TAKE-HOLD). ClinicalTrials.gov Identifier: NCT033279092017. https://clinicaltrials.gov/ct2/show/NCT03327909. Accessed November 22, 2020.
136.
ShermanRA, TorresF, CodyRP: Postprandial blood pressure changes during hemodialysis. Am J Kidney Dis12: 37–39, 1988PubMed
ShermanRA, TorresF, CodyRP: Postprandial blood pressure changes during hemodialysis. Am J Kidney Dis 12: 37–39, 1988PubMed)| false
ZoccaliC, MallamaciF, CiccarelliM, MaggioreQ: Postprandial alterations in arterial pressure control during hemodialysis in uremic patients. Clin Nephrol31: 323–326, 1989PubMed
ZoccaliC, MallamaciF, CiccarelliM, MaggioreQ: Postprandial alterations in arterial pressure control during hemodialysis in uremic patients. Clin Nephrol 31: 323–326, 1989PubMed)| false
EschbachJW, KellyMR, HaleyNR, AbelsRI, AdamsonJW: Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med321: 158–163, 1989PubMed
EschbachJW, KellyMR, HaleyNR, AbelsRI, AdamsonJW: Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321: 158–163, 1989PubMed)| false
EschbachJW, AbdulhadiMH, BrowneJK, DelanoBG, DowningMR, EgrieJC, et al.: Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial. Ann Intern Med111: 992–1000, 1989PubMed
EschbachJW, AbdulhadiMH, BrowneJK, DelanoBG, DowningMR, EgrieJC, : Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial. Ann Intern Med 111: 992–1000, 1989PubMed)| false
Van BurenPN, InrigJK: Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension. Semin Dial30: 545–552, 2017PubMed
Van BurenPN, InrigJK: Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension. Semin Dial 30: 545–552, 2017PubMed)| false
BondeAN, LipGY, KamperAL, HansenPR, LambertsM, HommelK, et al.: Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: A nationwide observational cohort study. J Am Coll Cardiol64: 2471–2482, 2014PubMed
BondeAN, LipGY, KamperAL, HansenPR, LambertsM, HommelK, : Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: A nationwide observational cohort study. J Am Coll Cardiol 64: 2471–2482, 2014PubMed)| false
VoskampPWM, RookmaakerMB, VerhaarMC, DekkerFW, OcakG: Vitamin K antagonist use and mortality in dialysis patients. Nephrol Dial Transplant33: 170–176, 2018PubMed
VoskampPWM, RookmaakerMB, VerhaarMC, DekkerFW, OcakG: Vitamin K antagonist use and mortality in dialysis patients. Nephrol Dial Transplant 33: 170–176, 2018PubMed)| false
LavilleM, DorvalM, Fort RosJ, FayR, CridligJ, NortierJL, et al.: Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis. Kidney Int86: 1260–1267, 2014PubMed
LavilleM, DorvalM, Fort RosJ, FayR, CridligJ, NortierJL, : Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis. Kidney Int 86: 1260–1267, 2014PubMed)| false
HuA, NiuJ, WinkelmayerWC: Oral anticoagulation in patients with end-stage kidney disease on dialysis and atrial fibrillation. Semin Nephrol38: 618–628, 2018PubMed
HuA, NiuJ, WinkelmayerWC: Oral anticoagulation in patients with end-stage kidney disease on dialysis and atrial fibrillation. Semin Nephrol 38: 618–628, 2018PubMed)| false
